FH and kidney neoplasm: Since the new WHO classification of kidney tumors presented late 2022 [14] was just beginning to enter into practice, we also performed Sanger sequencing of FH exons 1-10 for the patient’s brother (FH loss-of-function germline mutations cause FH-deficient RC, which was previously called papillary RC type 2).